Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Influenza in Birds"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
2 Not yet recruiting A Safety and Immunogenicity Study of IVACFLU-A/H5N1
Condition: Avian Influenza
Interventions: Biological: A/H5N1 vaccine;   Biological: Placebo Comparator
3 Recruiting Safety and Immunogenicity of IVACFLU-A/H5N1 in Vietnamese Adult
Condition: Influenza A/H5N1
Interventions: Biological: IVAC-H5N1-15ug;   Biological: IVAC-H5N1-30ug;   Biological: IVAC-placebo
4 Not yet recruiting Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
Condition: Influenza A Virus, H7N9 Subtype
Interventions: Biological: H7N9 pLAIV;   Biological: H7N9 pIIV;   Biological: AS03 adjuvant
5 Recruiting Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine.
Conditions: Avian Influenza;   H1N1 Influenza;   Influenza
Interventions: Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203;   Biological: Monovalent influenza A/H7N9 virus vaccine
6 Recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
Conditions: Avian Influenza;   Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
7 Recruiting Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults
Conditions: Influenza;   Healthy
Interventions: Biological: Multimeric 001 (M-001);   Biological: H5N1 influenza vaccine;   Biological: Saline
8 Recruiting A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2
9 Recruiting A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Condition: Influenza
Intervention: Biological: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).

Study has passed its completion date and status has not been verified in more than two years.